Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
12/09/2008 | CA2326045C Pde iv inhibiting pyridine derivatives |
12/09/2008 | CA2250188C Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
12/04/2008 | WO2008147956A2 Toll-like receptor 3 modulators and uses thereof |
12/04/2008 | WO2008147952A1 Modulators of cystic fibrosis transmembrane conductance regulator |
12/04/2008 | WO2008147697A1 Benzimidazolone chymase inhibitors |
12/04/2008 | WO2008147434A1 TREATMENT AND PREVENTION OF CHRONIC ASTHMA USING ANTAGONISTS OF INTEGRIN αVβ6 |
12/04/2008 | WO2008146919A1 Lincosamide derivative, and antibacterial agent comprising the same as active ingredient |
12/04/2008 | WO2008146917A1 Lincomycin derivatives and antibacterial agents containing the same as the active ingredient |
12/04/2008 | WO2008146914A1 Heterocyclic compound |
12/04/2008 | WO2008146871A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity |
12/04/2008 | WO2008146298A1 Use of aphanamixis polystacha extracts or fractions against 5 -lipoxygenase mediated diseases |
12/04/2008 | WO2008145688A2 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments |
12/04/2008 | WO2008145681A2 Ccr2 receptor antagonists and uses thereof |
12/04/2008 | WO2008145376A1 Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis |
12/04/2008 | WO2008145365A2 Treatment of surfactants with cyclodextrins |
12/04/2008 | WO2008145298A1 Reconstituted surfactants having improved properties |
12/04/2008 | WO2008144956A1 New ambroxol compounds, their preparation processes and uses |
12/04/2008 | WO2008144836A1 Sulphated xylans for treatment or prophylaxis of respiratory diseases |
12/04/2008 | WO2008144820A1 Treatment of chronic lung disease |
12/04/2008 | WO2008104808A3 Compounds and methods for the modulation of beta-1 integrin function to mediate tissue repair |
12/04/2008 | WO2008024277A3 Kw-3902 conjugates that do not cross the blood-brain barrier |
12/04/2008 | US20080300316 Substituted phenethylamines |
12/04/2008 | US20080300278 central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; gastrointestinal disorders; eating disorders; antidiabetic agents; anticancer agents; cardiovascular disorders |
12/04/2008 | US20080300275 Novel Benzothiazolone Derivatives |
12/04/2008 | US20080300268 Heterocyclic compounds and uses thereof |
12/04/2008 | US20080300255 Substituted pyrazoles |
12/04/2008 | US20080300253 Treatment of inflammatory disorders with praziquantel |
12/04/2008 | US20080300244 Novel compounds |
12/04/2008 | US20080300226 Combination of Anticholinergics and Glucocorticoids for the Long-Term Treatment of Asthma and COPD |
12/04/2008 | US20080299208 Anisometric Particles In The Form Of Nanofibers/Mesofibers,Nanopipes, Nanocables/Mesocables, Nanobands/Mesobands, And The Curved Or Branched Variations Thereof |
12/04/2008 | US20080299207 Methods and compositions for administration of oxybutynin |
12/04/2008 | US20080299138 Toll-Like Receptor 3 Modulators and Uses Thereof |
12/04/2008 | US20080299134 Recombinant Anti-Interleukin-9 Antibodies |
12/04/2008 | US20080299129 Antagonists to il-17a, il-17f, and il-23p19 and methods of use |
12/04/2008 | US20080299116 Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof |
12/04/2008 | US20080299114 Humaneered anti-factor b antibody |
12/04/2008 | US20080299089 Endogeneous repair factor production promoters |
12/04/2008 | US20080299081 Polynucleotides and Polypeptides of the IFNalpha-21 Gene |
12/04/2008 | US20080299045 Composition for Prevention, Treatment, and Diagnosis of Chronic Obstructive Pulmonary Disease (Copd) |
12/04/2008 | DE102007025898A1 Behandlung von Surfactanten Treatment of surfactants |
12/04/2008 | CA2689075A1 Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis |
12/04/2008 | CA2689066A1 Reconstituted surfactants having improved properties |
12/04/2008 | CA2688004A1 Modulators of cystic fibrosis transmembrane conductance regulator |
12/04/2008 | CA2687948A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein andhas glucocorticoid receptor-binding activity |
12/04/2008 | CA2687931A1 Ccr2 receptor antagonists and uses thereof |
12/04/2008 | CA2687821A1 Benzimidazolone chymase inhibitors |
12/04/2008 | CA2665885A1 Treatment and prevention of chronic asthma using antagonists of integrin .alpha.nu.beta.6 |
12/03/2008 | EP1997823A1 Boronic ester and acid compounds, synthesis and uses |
12/03/2008 | EP1997502A1 Reconstituted surfactants having improved properties |
12/03/2008 | EP1997494A2 Modulators of hedgehog signaling pathways, compositions and uses related thereto |
12/03/2008 | EP1996566A1 Bezothiazol derivatives as beta2 adrenoreceptor agonists |
12/03/2008 | EP1996559A1 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
12/03/2008 | EP1996551A2 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them. |
12/03/2008 | EP1996179A2 Compositions for disorders associated with metachromatic cell activation |
12/03/2008 | EP1513516B1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES |
12/03/2008 | EP1511499B1 Immunomodulatory compounds and methods of use thereof |
12/03/2008 | EP1480954B1 Vanilloid receptor modulators |
12/03/2008 | EP1383787B1 Sapogenin derivatives, their synthesis and use |
12/03/2008 | EP1377540B1 Inhibitors of integrin alpha-v-beta-6 |
12/03/2008 | EP1373218B9 Imidazolyl derivatives useful as histamine h3 receptor ligands |
12/03/2008 | EP1305330B1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents |
12/03/2008 | CN101316829A Oxadiazole derivatives with crth2 receptor activity |
12/03/2008 | CN101316599A Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of NKT cell as active ingredient |
12/03/2008 | CN101316591A Quinolines and their therapeutic use |
12/03/2008 | CN101314015A Medicament for treating children's asthma |
12/03/2008 | CN101313986A Orally taken traditional Chinese medicine for treating cough caused by dryness-heat |
12/03/2008 | CN101313956A Compound chrysanthemum capsule |
12/03/2008 | CN101313947A Method for preventing fluff fly in folium eriobotryae process |
12/03/2008 | CN101313945A Compound houttuynia cordata capsule |
12/03/2008 | CN101313938A Magnolia flower volatile oil spray for nose |
12/03/2008 | CN101313914A Uses and preparations of common camptotheca fruit glycosides of common camptotheca fruit extract |
12/03/2008 | CN101313891A Palmatine injection and preparation method thereof |
12/03/2008 | CN101313730A Pig feed containing Chinese medicinal herb and preparation method thereof |
12/03/2008 | CN100439400C Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
12/03/2008 | CN100439399C Human antibodies that bind human IL-12 and methods for producing |
12/03/2008 | CN100439394C Pharmaceutical use for secreted bacterial effector proteins |
12/03/2008 | CN100439340C 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
12/03/2008 | CN100439332C Novel thiourea derivatives and the pharmaceutical compositions containing thd same |
12/03/2008 | CN100438918C Vaccine against SARS virogene and its preparation method and use |
12/03/2008 | CN100438912C Self-assembled luminous current-conducting nano medicine crystal and ultra-thin film and preparation method thereof |
12/03/2008 | CN100438905C Stable liquid formulations of botulinum toxin |
12/03/2008 | CN100438904C Chinese medicine for clearing away heat and toxic matter to prevent and treat common cold and the method of preparing herb tea, oral liquid and granule therewith |
12/03/2008 | CN100438893C Asthma-relieving liquor and its preparation process |
12/03/2008 | CN100438888C Freeze-dried preparation containing honeysuckle flower and astragalus root and its preparing method |
12/03/2008 | CN100438877C (20s) 1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
12/03/2008 | CN100438862C Composition for administration to mucosa and containing coenzyme Q as active ingredient |
12/02/2008 | US7459540 Fibroblast growth factor-like polypeptides |
12/02/2008 | US7459463 Crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a] pyridine-6-carboxamide mesylate salt |
12/02/2008 | US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism |
12/02/2008 | US7459453 Pyridazin-3(2H)-one derivatives as PDE4 inhibitors |
12/02/2008 | US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells |
12/02/2008 | US7459171 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area of penetrants; drug delivery |
12/02/2008 | US7459165 isolated polypeptide consisting of the amino acid sequence set forth as SEQ ID NO:4 from which the signal peptide sequence set forth as SEQ ID NO:38 is deleted; Pseudomonas aeruginosa infection |
12/02/2008 | US7459158 Can be used to vaccinate a mammal against specific self or non-self antigens |
12/02/2008 | CA2361841C Mevinolin derivatives |
12/02/2008 | CA2341624C Stable spray-dried protein formulations |
12/02/2008 | CA2182062C Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents, and medicaments comprising them |
11/27/2008 | WO2008144720A2 Inhibitors of igf-1r signaling for the treatment of respiratory disorders |
11/27/2008 | WO2008144473A2 Chimeric pufa polyketide synthase systems and uses thereof |
11/27/2008 | WO2008144347A1 Combinations comprising a fluoroquinolone for treating, reducing, ameliorating, or preventing infections |